title: Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
abstract: BACKGROUND
  Ovulation induction drugs may be associated with increased breast cancer risk. Results so far have been inconclusive.
  
  
  OBJECTIVE
  To evaluate the association between infertility, exposure to ovulation induction drugs and the incidence of breast cancer.
  
  
  METHODS
  Historical prospective cohort and nested case-control study.
  
  
  METHODS
  Institutional practice
  
  
  METHODS
  About 5,788 women attending five infertility centers in Israel between 1964 and 1984.
  
  
  OBJECTIVE
  Abstracting of medical records and telephone interviews.
  
  
  METHODS
  Breast cancer incidence was determined through linkage with the National Cancer Registry database. Standardized incidence ratios (SIRs) and 95% confidence intervals were computed by comparing the observed to the expected cancer rates in the general population. In addition, a nested case-control study within the cohort was performed with interviews of breast cancer cases and two matched controls.
  
  
  RESULTS
  The study cohort included 120,895 women years of follow-up. Compared to 115.2 expected breast cancer cases, 131 cases were observed (SIR = 1.1; 95% CI 0.9-1.4). Risk for breast cancer was significantly higher for women treated with clomiphene citrate (SIR = 1.4; 95% CI 1.0-1.8). Similar results were noted when comparisons were carried out between treated and untreated women, and when multivariate models were applied. In the nested case-control study, higher cycle index (OR = 2.2; 95% CI 1.0-4.8) and treatment with clomiphene citrate (OR=2.7; 95% CI 1.3-5.7) were associated with higher risk for breast cancer.
  
  
  CONCLUSIONS
  Infertility and usage of infertility drugs in general are not associated with increased risk for breast cancer. However, for infertile women treated with clomiphene citrate, breast cancer risk is elevated.
authors: Women and Children's Health Research Unit, Sheba Medical Center, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer, Ramat Gan 52621, Israel. Liatl@gertner.health.gov.il
authors: L
authors: L
authors: Lerner-Geva
authors: L
authors: L
authors: Keinan-Boker
authors: T
authors: T
authors: Blumstein
authors: V
authors: V
authors: Boyko
authors: L
authors: L
authors: Olmar
authors: S
authors: S
authors: Mashiach
authors: J
authors: J
authors: Rabinovici
authors: G
authors: G
authors: Potashnik
authors: E
authors: E
authors: Lunenfeld
authors: J G
authors: JG
authors: Schenker
authors: A
authors: A
authors: Shushan
authors: A
authors: A
authors: Fishman
authors: I
authors: I
authors: Cohen
authors: I
authors: I
authors: Vagman
authors: B
authors: B
authors: Lunenfeld